Results 261 to 270 of about 1,197,904 (347)

Hepatitis B Virus Treatment Gaps in the US.

JAMA Netw Open
Wong RJ, Telep LE, Wentworth CE, Liu Y, Iqbal S, Naik SD, Chiang B, Bhattacharya A, Singer AW, Chokkalingam AP, Frenette CT, Yee LJ.   +11 more
europepmc   +1 more source

Hepatitis B virus integration and hepatocarcinogenesis. [PDF]

Liver Res
Ma L, Chen S, Wang H, Chen L.
europepmc   +1 more source

Curcuminoids amplify host innate antiviral immunity via the CRYAB‐RBM26 axis in viral infection

iMeta, EarlyView.
DMC/CUR antagonize viral hijacking of host nucleic acid resources and finely regulate the induction and effector phases of the type I interferon (IFN‐I) pathway through the CRYAB‐RBM26 axis. This molecular axis serves as a key downstream regulator for DMC/CUR activation of the IFN‐I pathway.
Tingting Chen, Xiang Wang, Guangyuan Zhang, Lu Wang, Junhao Wan, Lirong Tan, Xinyue Fan, Siqin Meng, Zhixing Jin, Yuzhang Liang, Haoze Li, Ziyuan Wan, Xiaotong Xu, Yan Zhang, Li Qin, Anna Malashicheva, Yu Du, Guangchao Zang, Guixue Wang   +18 more
wiley   +1 more source

A comparison of hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: a bioinformatics analysis. [PDF]

Transl Cancer Res
Huang Y, Chen G, Fan H, Wang S, Yuan H, Liu Z, Zhang T.   +6 more
europepmc   +1 more source

Microbial metabolites in tumor epigenetic regulation

iMeta, EarlyView.
The gut microbiome modulates tumor epigenetic regulation through bioactive metabolites derived from dietary substrates. Microbiota‐produced SCFAs, secondary BAs, one‐carbon metabolites, and tryptophan‐derived ligands regulate histone acetylation, DNA methylation, and chromatin remodeling via HDAC, DNMT, AhR, and metabolic cofactor‐dependent pathways ...
Wangzheqi Zhang, Haoling Zhang, Yan Liao, Shuya Jiang, Haolong Zhang, Chenwei Huang, Zhijing Song, Rui Zhao, Ping Lu, Xiaohong Kang, Eryan Kong, Yalin Zhu, Wei Wang, Xuesong Liu, Yisheng Chen, Zhiwen Luo, Zhaoyu Li, Di Wang, Na Xing, Yadong Guo, Jingjing Zhang, Xiaojing Wang, Wenyi Wang, Mowaffaq Adam, Bakiah Shaharuddin, Muhamad Yusri Musa, Doblin Sandai, Chenglong Zhu, Aimin Jiang, Peng Luo, Zhijie Zhao, Zui Zou   +31 more
wiley   +1 more source

Sjögren's syndrome and hepatitis C virus infection presenting as hypokalemic quadriparesis: A case report. [PDF]

J Int Med Res
Joshi A, Risal UP, Sah NK, Shah B.
europepmc   +1 more source

PD‐1/PD‐L1 in Hepatocellular Carcinoma (2014–2024): A Combined Macro and Micro Analysis of Immunotherapy Implications

iNew Medicine, EarlyView.
ABSTRACT Hepatocellular carcinoma (HCC) represents a significant global health issue, with the PD‐1/PD‐L1 axis serving a pivotal target for immunotherapy in this malignancy. However, a comprehensive bibliometric analysis of PD‐1/PD‐L1 research in HCC is lacking.
Xingyu Zhu, Lin Tang, Hongyan Li, Hao Li, Jiamei Wang   +4 more
wiley   +1 more source

Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials

iNew Medicine, EarlyView.
ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong, Xiao‐Yu Shen, Han‐Cheng Jin, Xiang‐Yu Li, Hao He, Xiao‐Ming Meng   +5 more
wiley   +1 more source

A comprehensive review on seroepidemiology and molecular epidemiology of hepatitis E Virus in Iran. [PDF]

Gastroenterol Hepatol Bed Bench
Aghapour AH, Hosseini SM, Shoraka S, Ghaemi A, Sharifian A, Mohebbi SR.   +5 more
europepmc   +1 more source

Gut microbiome‐derived metabolites show promise in cancer research and therapy

Interdisciplinary Medicine, EarlyView.
The metabolites produced by the gut microbiome, which are subject to regulation by multiple factors, play a pivotal role in the progression of various types of cancer. These metabolites not only function as potential biomarkers for the early detection and monitoring of tumor development, but also actively participate in cancer therapeutic processes ...
Kangjie Yang, Yifan Wang, Daolin Tang, Peilong Li, Lutao Du   +4 more
wiley   +1 more source